LifeHealthcare Group (ASX:LHC) has entered into a scheme implementation deed with a subsidiary of Australian private equity firm Pacific Equity Partners, Pacific Health Supplies.
The scheme implies a fully diluted market capitalisation for LifeHealthcare of $179 million and an enterprise value of approximately $211 million.
The scheme is subject to approval from shareholders, who will be entitled to receive $3.75 per share.
The price represents a 46 per cent premium to the closing share price on 2 February 2018.
LifeHealthcare will pay a fully franked interim dividend of $0.18 cents per share with $0.08 per share in franking credits attached.
Shares in LifeHealthcare Group (ASX:LHC) are trading 41.25 per cent higher at $3.63.